Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Health Reform Deal Is Not Binding On House, Rep. Waxman Declares

This article was originally published in The Pink Sheet Daily

Executive Summary

Waxman will keep pushing for Part D rebates to help fund closing the coverage gap, regardless of PhRMA's proposal for a different discount model. The good news for industry is that "dollars for donuts" remains the formula--and that even Waxman thinks industry will end up getting more than it gives.
Advertisement

Related Content

Waxman’s Congressional Exclusivity Set To Expire, But There Will Be No Equivalents
Congressmen With Key Health Care Oversight Jurisdiction Named To "Super Committee"
Rep. Waxman Will Support Targeted Document Requests On White House Health Reform Deals
Drug Co-Pay Subsidies From Pharma At Odds With Goals Of Health Reform - Medco
Rx Contribution To Health Reform May Be $100 Bil. After All, Obama Suggests
House Takes Up PhRMA Offer For Rx Discounts In Donut Hole, But Still Wants More Rebates
Playing Defense In The House: PhRMA's Donut Hole Deal Garners Support From Democrats
Part D Rebates Can Pay For Filling In Donut Hole, CBO Says
Part D Rebates Can Pay For Filling In Donut Hole, CBO Says
PhRMA Donut Hole Pledge Sets Nice Tone, But Negotiations Continue On $80 Bil. Contribution

Topics

Advertisement
UsernamePublicRestriction

Register

PS069810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel